This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-362-3p | ABCA1 | 0.11 | 0.64379 | -0.05 | 0.8308 | miRanda | -0.27 | 0 | NA | |
2 | hsa-miR-362-3p | ABCA6 | 0.11 | 0.64379 | -0.41 | 0.30457 | miRanda | -0.49 | 1.0E-5 | NA | |
3 | hsa-miR-362-3p | ABCC9 | 0.11 | 0.64379 | -0.58 | 0.0487 | miRanda | -0.5 | 0 | NA | |
4 | hsa-miR-362-3p | ABCD2 | 0.11 | 0.64379 | -0.21 | 0.52359 | miRanda | -0.3 | 0.00143 | NA | |
5 | hsa-miR-362-3p | ACAN | 0.11 | 0.64379 | -0.41 | 0.10954 | miRanda | -0.17 | 0.02006 | NA | |
6 | hsa-miR-362-3p | ACER2 | 0.11 | 0.64379 | -0.48 | 0.01435 | miRanda | -0.19 | 0.00079 | NA | |
7 | hsa-miR-362-3p | ADAM28 | 0.11 | 0.64379 | -0.48 | 0.15863 | PITA | -0.24 | 0.01584 | NA | |
8 | hsa-miR-362-3p | ADAM33 | 0.11 | 0.64379 | -0.33 | 0.4232 | miRanda | -0.41 | 0.0005 | NA | |
9 | hsa-miR-362-3p | ADAMTS1 | 0.11 | 0.64379 | -0.39 | 0.09809 | miRanda | -0.3 | 0 | NA | |
10 | hsa-miR-362-3p | ADAMTS4 | 0.11 | 0.64379 | -0.28 | 0.27653 | miRanda | -0.23 | 0.00078 | NA | |
11 | hsa-miR-362-3p | ADAMTSL1 | 0.11 | 0.64379 | -0.13 | 0.64223 | miRanda | -0.33 | 7.0E-5 | NA | |
12 | hsa-miR-362-3p | ADAMTSL4 | 0.11 | 0.64379 | -0.41 | 0.09478 | miRNATAP | -0.24 | 0.00059 | NA | |
13 | hsa-miR-362-3p | ADCY1 | 0.11 | 0.64379 | -0.69 | 0.01679 | miRanda | -0.32 | 0.00014 | NA | |
14 | hsa-miR-362-3p | ADCYAP1 | 0.11 | 0.64379 | -0.2 | 0.67185 | miRanda | -0.63 | 0 | NA | |
15 | hsa-miR-362-3p | ADD2 | 0.11 | 0.64379 | -0.98 | 0.01735 | PITA; miRanda | -0.55 | 0 | NA | |
16 | hsa-miR-362-3p | AFF4 | 0.11 | 0.64379 | -0.05 | 0.75124 | PITA | -0.12 | 0 | NA | |
17 | hsa-miR-362-3p | AGAP11 | 0.11 | 0.64379 | -0.07 | 0.78145 | miRanda | -0.18 | 0.01802 | NA | |
18 | hsa-miR-362-3p | AGPAT4 | 0.11 | 0.64379 | -0.78 | 0.00264 | MirTarget | -0.32 | 1.0E-5 | NA | |
19 | hsa-miR-362-3p | AHNAK | 0.11 | 0.64379 | -0.62 | 0.01795 | PITA; miRanda; miRNATAP | -0.22 | 3.0E-5 | NA | |
20 | hsa-miR-362-3p | AK5 | 0.11 | 0.64379 | -0.8 | 0.01153 | miRanda | -0.35 | 0.00012 | NA | |
21 | hsa-miR-362-3p | AKAP2 | 0.11 | 0.64379 | 0.17 | 0.40729 | PITA; miRNATAP | -0.25 | 1.0E-5 | NA | |
22 | hsa-miR-362-3p | AKT3 | 0.11 | 0.64379 | -0.59 | 0.01641 | miRanda | -0.42 | 0 | NA | |
23 | hsa-miR-362-3p | ALCAM | 0.11 | 0.64379 | -0.18 | 0.41514 | miRanda | -0.1 | 0.04247 | NA | |
24 | hsa-miR-362-3p | ALDH1A2 | 0.11 | 0.64379 | -1.71 | 0.00293 | miRanda | -0.4 | 0.02021 | NA | |
25 | hsa-miR-362-3p | AMOTL1 | 0.11 | 0.64379 | -0.76 | 0.00615 | MirTarget | -0.45 | 0 | NA | |
26 | hsa-miR-362-3p | ANGPTL2 | 0.11 | 0.64379 | -0.63 | 0.02845 | miRanda; miRNATAP | -0.44 | 0 | NA | |
27 | hsa-miR-362-3p | ANKRD44 | 0.11 | 0.64379 | -0.5 | 0.04561 | miRanda | -0.23 | 0.00135 | NA | |
28 | hsa-miR-362-3p | ANKRD6 | 0.11 | 0.64379 | -0.33 | 0.13971 | miRanda | -0.2 | 0.00215 | NA | |
29 | hsa-miR-362-3p | ANO1 | 0.11 | 0.64379 | -1.17 | 0.00028 | miRanda | -0.27 | 0.00287 | NA | |
30 | hsa-miR-362-3p | AP4S1 | 0.11 | 0.64379 | -0.09 | 0.55098 | miRanda | -0.12 | 0.00739 | NA | |
31 | hsa-miR-362-3p | APBA2 | 0.11 | 0.64379 | -0.62 | 0.01322 | miRanda; miRNATAP | -0.28 | 9.0E-5 | NA | |
32 | hsa-miR-362-3p | APBB1IP | 0.11 | 0.64379 | -0.53 | 0.06348 | miRanda | -0.33 | 8.0E-5 | NA | |
33 | hsa-miR-362-3p | APOOL | 0.11 | 0.64379 | 0.18 | 0.28233 | miRanda | -0.13 | 0.00821 | NA | |
34 | hsa-miR-362-3p | AR | 0.11 | 0.64379 | -0.72 | 0.08465 | miRanda | -0.59 | 0 | NA | |
35 | hsa-miR-362-3p | ARHGEF15 | 0.11 | 0.64379 | -0.54 | 0.00479 | miRanda | -0.22 | 5.0E-5 | NA | |
36 | hsa-miR-362-3p | ARHGEF6 | 0.11 | 0.64379 | -0.48 | 0.03477 | MirTarget; miRanda | -0.32 | 0 | NA | |
37 | hsa-miR-362-3p | ARL10 | 0.11 | 0.64379 | -0.13 | 0.63188 | mirMAP | -0.33 | 1.0E-5 | NA | |
38 | hsa-miR-362-3p | ARL4C | 0.11 | 0.64379 | -0.39 | 0.13323 | PITA | -0.32 | 0 | NA | |
39 | hsa-miR-362-3p | ARL4D | 0.11 | 0.64379 | 0.07 | 0.75696 | miRNATAP | -0.18 | 0.00433 | NA | |
40 | hsa-miR-362-3p | ARMC9 | 0.11 | 0.64379 | -0.32 | 0.03253 | miRanda | -0.12 | 0.00121 | NA | |
41 | hsa-miR-362-3p | ARNT2 | 0.11 | 0.64379 | -0.83 | 0.01329 | miRanda | -0.36 | 0.0002 | NA | |
42 | hsa-miR-362-3p | ASAP1 | 0.11 | 0.64379 | 0.16 | 0.3669 | miRanda | -0.11 | 0.00754 | NA | |
43 | hsa-miR-362-3p | ASXL2 | 0.11 | 0.64379 | -0.01 | 0.96811 | miRanda | -0.16 | 3.0E-5 | NA | |
44 | hsa-miR-362-3p | ATP10A | 0.11 | 0.64379 | -0.48 | 0.07791 | miRanda | -0.39 | 0 | NA | |
45 | hsa-miR-362-3p | ATXN1 | 0.11 | 0.64379 | -0.19 | 0.22524 | MirTarget; PITA; miRanda; miRNATAP | -0.15 | 0 | NA | |
46 | hsa-miR-362-3p | B3GALT1 | 0.11 | 0.64379 | -0.92 | 0.05694 | miRanda | -0.34 | 0.01452 | NA | |
47 | hsa-miR-362-3p | B3GNT9 | 0.11 | 0.64379 | -0.42 | 0.00761 | miRanda | -0.11 | 0.00601 | NA | |
48 | hsa-miR-362-3p | BAALC | 0.11 | 0.64379 | -0.56 | 0.07918 | miRanda | -0.44 | 0 | NA | |
49 | hsa-miR-362-3p | BAHCC1 | 0.11 | 0.64379 | -0.14 | 0.5649 | PITA; miRanda | -0.24 | 0.00056 | NA | |
50 | hsa-miR-362-3p | BCL6 | 0.11 | 0.64379 | -0.43 | 0.02067 | miRanda | -0.15 | 0.00147 | NA | |
51 | hsa-miR-362-3p | BEND4 | 0.11 | 0.64379 | -0.57 | 0.13158 | miRanda | -0.35 | 0.00126 | NA | |
52 | hsa-miR-362-3p | BEX4 | 0.11 | 0.64379 | -0.56 | 0.02756 | miRanda | -0.3 | 4.0E-5 | NA | |
53 | hsa-miR-362-3p | BHLHE22 | 0.11 | 0.64379 | -0.08 | 0.78042 | miRanda | -0.3 | 0.00045 | NA | |
54 | hsa-miR-362-3p | BMF | 0.11 | 0.64379 | 0.05 | 0.80648 | PITA; miRanda; miRNATAP | -0.11 | 0.03223 | NA | |
55 | hsa-miR-362-3p | BMP6 | 0.11 | 0.64379 | -0.95 | 0 | miRanda | -0.21 | 0.00048 | NA | |
56 | hsa-miR-362-3p | BMPR1B | 0.11 | 0.64379 | -1.56 | 0.00021 | MirTarget; miRanda | -0.58 | 0 | NA | |
57 | hsa-miR-362-3p | BMPR2 | 0.11 | 0.64379 | -0.08 | 0.64874 | MirTarget; PITA; miRanda; miRNATAP | -0.15 | 1.0E-5 | NA | |
58 | hsa-miR-362-3p | BTK | 0.11 | 0.64379 | -0.56 | 0.06441 | miRanda | -0.37 | 3.0E-5 | NA | |
59 | hsa-miR-362-3p | CACNA1B | 0.11 | 0.64379 | -1.82 | 0.00013 | MirTarget; miRNATAP | -0.39 | 0.00442 | NA | |
60 | hsa-miR-362-3p | CACNA2D1 | 0.11 | 0.64379 | -0.85 | 0.05575 | miRanda | -0.78 | 0 | NA | |
61 | hsa-miR-362-3p | CADM1 | 0.11 | 0.64379 | -0.57 | 0.06122 | PITA; miRanda; miRNATAP | -0.41 | 0 | NA | |
62 | hsa-miR-362-3p | CADM3 | 0.11 | 0.64379 | -0.5 | 0.33965 | miRanda | -0.76 | 0 | NA | |
63 | hsa-miR-362-3p | CALCRL | 0.11 | 0.64379 | -0.45 | 0.04092 | miRanda | -0.33 | 0 | NA | |
64 | hsa-miR-362-3p | CAMK2B | 0.11 | 0.64379 | -0.01 | 0.97166 | miRanda | -0.39 | 0.00026 | NA | |
65 | hsa-miR-362-3p | CAMK4 | 0.11 | 0.64379 | -0.8 | 0.0051 | miRanda | -0.25 | 0.00198 | NA | |
66 | hsa-miR-362-3p | CAPN14 | 0.11 | 0.64379 | -0.42 | 0.33347 | miRanda | -0.27 | 0.02922 | NA | |
67 | hsa-miR-362-3p | CASS4 | 0.11 | 0.64379 | -0.55 | 0.04983 | miRanda | -0.32 | 7.0E-5 | NA | |
68 | hsa-miR-362-3p | CBLN2 | 0.11 | 0.64379 | 0.33 | 0.35314 | miRanda | -0.2 | 0.04895 | NA | |
69 | hsa-miR-362-3p | CBX6 | 0.11 | 0.64379 | -0.16 | 0.54398 | mirMAP | -0.3 | 0.00011 | NA | |
70 | hsa-miR-362-3p | CC2D2A | 0.11 | 0.64379 | 0.14 | 0.60106 | miRanda | -0.25 | 0.00089 | NA | |
71 | hsa-miR-362-3p | CCDC102B | 0.11 | 0.64379 | -0.36 | 0.06947 | miRanda | -0.18 | 0.00154 | NA | |
72 | hsa-miR-362-3p | CCDC85A | 0.11 | 0.64379 | -0.26 | 0.35716 | miRanda; miRNATAP | -0.37 | 1.0E-5 | NA | |
73 | hsa-miR-362-3p | CCDC89 | 0.11 | 0.64379 | -0.04 | 0.849 | miRanda | -0.16 | 0.01666 | NA | |
74 | hsa-miR-362-3p | CCL19 | 0.11 | 0.64379 | -0.2 | 0.71713 | miRanda | -0.49 | 0.00241 | NA | |
75 | hsa-miR-362-3p | CCNJL | 0.11 | 0.64379 | -0.46 | 0.06809 | miRanda | -0.22 | 0.00205 | NA | |
76 | hsa-miR-362-3p | CCPG1 | 0.11 | 0.64379 | -0.39 | 0.02629 | miRanda | -0.12 | 0.00048 | NA | |
77 | hsa-miR-362-3p | CD36 | 0.11 | 0.64379 | -0.56 | 0.10855 | miRanda | -0.36 | 0.00049 | NA | |
78 | hsa-miR-362-3p | CD79B | 0.11 | 0.64379 | -0.28 | 0.39374 | PITA; miRanda | -0.22 | 0.02274 | NA | |
79 | hsa-miR-362-3p | CDH11 | 0.11 | 0.64379 | -0.86 | 0.00288 | miRanda | -0.43 | 0 | NA | |
80 | hsa-miR-362-3p | CDH13 | 0.11 | 0.64379 | -0.45 | 0.02591 | MirTarget; miRanda | -0.19 | 0.0004 | NA | |
81 | hsa-miR-362-3p | CDYL2 | 0.11 | 0.64379 | -0.42 | 0.08783 | miRanda | -0.28 | 8.0E-5 | NA | |
82 | hsa-miR-362-3p | CFH | 0.11 | 0.64379 | -0.52 | 0.05574 | miRanda | -0.42 | 0 | NA | |
83 | hsa-miR-362-3p | CHL1 | 0.11 | 0.64379 | -0.75 | 0.06297 | miRanda | -0.61 | 0 | NA | |
84 | hsa-miR-362-3p | CHRDL1 | 0.11 | 0.64379 | -0.12 | 0.84302 | PITA; miRanda; miRNATAP | -0.88 | 0 | NA | |
85 | hsa-miR-362-3p | CLCF1 | 0.11 | 0.64379 | -0.01 | 0.94286 | miRanda | -0.14 | 0.00726 | NA | |
86 | hsa-miR-362-3p | CLIP4 | 0.11 | 0.64379 | -0.43 | 0.14009 | miRanda | -0.48 | 0 | NA | |
87 | hsa-miR-362-3p | CLU | 0.11 | 0.64379 | 0.02 | 0.95834 | miRanda | -0.22 | 0.019 | NA | |
88 | hsa-miR-362-3p | CMTM3 | 0.11 | 0.64379 | -0.4 | 0.05724 | miRanda | -0.29 | 0 | NA | |
89 | hsa-miR-362-3p | CNNM1 | 0.11 | 0.64379 | 0.03 | 0.92696 | miRanda | -0.38 | 0.00015 | NA | |
90 | hsa-miR-362-3p | CNPY4 | 0.11 | 0.64379 | -0.17 | 0.22383 | miRanda | -0.12 | 0.00044 | NA | |
91 | hsa-miR-362-3p | CNR1 | 0.11 | 0.64379 | -0.02 | 0.96823 | miRanda | -0.66 | 0 | NA | |
92 | hsa-miR-362-3p | COL11A1 | 0.11 | 0.64379 | -1.04 | 0.02407 | miRanda | -0.63 | 0 | NA | |
93 | hsa-miR-362-3p | COL13A1 | 0.11 | 0.64379 | -0.36 | 0.15915 | miRanda | -0.15 | 0.04683 | NA | |
94 | hsa-miR-362-3p | COL24A1 | 0.11 | 0.64379 | -1.04 | 0.00275 | miRanda | -0.53 | 0 | NA | |
95 | hsa-miR-362-3p | COL4A1 | 0.11 | 0.64379 | -0.46 | 0.06991 | miRanda | -0.23 | 1.0E-5 | NA | |
96 | hsa-miR-362-3p | COL5A3 | 0.11 | 0.64379 | -0.29 | 0.25685 | miRanda | -0.19 | 0.00776 | NA | |
97 | hsa-miR-362-3p | COL6A3 | 0.11 | 0.64379 | -0.68 | 0.04435 | miRanda | -0.42 | 0 | NA | |
98 | hsa-miR-362-3p | CORIN | 0.11 | 0.64379 | -0.51 | 0.16112 | miRanda | -0.43 | 5.0E-5 | NA | |
99 | hsa-miR-362-3p | CPEB4 | 0.11 | 0.64379 | -0.14 | 0.38436 | PITA; miRanda; miRNATAP | -0.17 | 0 | NA | |
100 | hsa-miR-362-3p | CR2 | 0.11 | 0.64379 | -0.52 | 0.38404 | miRanda | -0.4 | 0.02325 | NA | |
101 | hsa-miR-362-3p | CREB5 | 0.11 | 0.64379 | 0.1 | 0.71971 | PITA | -0.25 | 0.00256 | NA | |
102 | hsa-miR-362-3p | CRIP2 | 0.11 | 0.64379 | -0.59 | 0.00305 | miRanda | -0.22 | 1.0E-5 | NA | |
103 | hsa-miR-362-3p | CRK | 0.11 | 0.64379 | -0.35 | 0.02694 | miRanda | -0.12 | 0.00011 | NA | |
104 | hsa-miR-362-3p | CRMP1 | 0.11 | 0.64379 | -0.15 | 0.5174 | MirTarget; PITA; miRanda; miRNATAP | -0.33 | 0 | NA | |
105 | hsa-miR-362-3p | CSGALNACT1 | 0.11 | 0.64379 | -0.38 | 0.07842 | miRanda | -0.2 | 0.00133 | NA | |
106 | hsa-miR-362-3p | CX3CR1 | 0.11 | 0.64379 | -0.11 | 0.7119 | miRanda | -0.36 | 2.0E-5 | NA | |
107 | hsa-miR-362-3p | CXCL12 | 0.11 | 0.64379 | -0.53 | 0.05256 | miRanda | -0.29 | 0.00013 | NA | |
108 | hsa-miR-362-3p | CXCL6 | 0.11 | 0.64379 | -0.01 | 0.97986 | miRanda | -0.26 | 0.02983 | NA | |
109 | hsa-miR-362-3p | CXCR1 | 0.11 | 0.64379 | -0.72 | 0.11406 | miRanda | -0.37 | 0.00538 | NA | |
110 | hsa-miR-362-3p | CYP26B1 | 0.11 | 0.64379 | -0.82 | 0.00608 | miRanda | -0.26 | 0.00362 | NA | |
111 | hsa-miR-362-3p | CYTH4 | 0.11 | 0.64379 | -0.65 | 0.0106 | miRanda | -0.27 | 0.00023 | NA | |
112 | hsa-miR-362-3p | DAAM1 | 0.11 | 0.64379 | -0.28 | 0.04584 | MirTarget; miRanda; miRNATAP | -0.16 | 1.0E-5 | NA | |
113 | hsa-miR-362-3p | DACT1 | 0.11 | 0.64379 | -0.88 | 0.00156 | miRanda | -0.32 | 4.0E-5 | NA | |
114 | hsa-miR-362-3p | DAPK1 | 0.11 | 0.64379 | -1.39 | 1.0E-5 | PITA; miRanda; miRNATAP | -0.23 | 0.01432 | NA | |
115 | hsa-miR-362-3p | DCLK1 | 0.11 | 0.64379 | -0.52 | 0.16756 | miRanda | -0.59 | 0 | NA | |
116 | hsa-miR-362-3p | DCLK2 | 0.11 | 0.64379 | -0.72 | 0.00239 | miRanda | -0.31 | 1.0E-5 | NA | |
117 | hsa-miR-362-3p | DENND5A | 0.11 | 0.64379 | -0.27 | 0.13541 | miRanda | -0.2 | 1.0E-5 | NA | |
118 | hsa-miR-362-3p | DFNA5 | 0.11 | 0.64379 | -0.65 | 0.01802 | miRanda | -0.41 | 0 | NA | |
119 | hsa-miR-362-3p | DISC1 | 0.11 | 0.64379 | -0.39 | 0.02323 | miRanda | -0.19 | 0.00015 | NA | |
120 | hsa-miR-362-3p | DKK3 | 0.11 | 0.64379 | -0.46 | 0.04838 | miRanda | -0.32 | 0 | NA | |
121 | hsa-miR-362-3p | DLC1 | 0.11 | 0.64379 | -0.42 | 0.0471 | miRanda | -0.29 | 0 | NA | |
122 | hsa-miR-362-3p | DMPK | 0.11 | 0.64379 | -0.27 | 0.10001 | miRanda | -0.12 | 0.00181 | NA | |
123 | hsa-miR-362-3p | DNM3 | 0.11 | 0.64379 | 0.41 | 0.1412 | MirTarget; PITA; miRanda; miRNATAP | -0.16 | 0.0459 | NA | |
124 | hsa-miR-362-3p | DOK6 | 0.11 | 0.64379 | -0.35 | 0.17852 | miRNATAP | -0.43 | 0 | NA | |
125 | hsa-miR-362-3p | DPP10 | 0.11 | 0.64379 | -0.38 | 0.52965 | miRanda | -0.46 | 0.00855 | NA | |
126 | hsa-miR-362-3p | DPYD | 0.11 | 0.64379 | -0.92 | 0.00346 | miRanda | -0.43 | 0 | NA | |
127 | hsa-miR-362-3p | DPYSL3 | 0.11 | 0.64379 | -0.83 | 0.0062 | PITA; miRanda; miRNATAP | -0.62 | 0 | NA | |
128 | hsa-miR-362-3p | DTNA | 0.11 | 0.64379 | -0.6 | 0.13401 | PITA; miRanda; miRNATAP | -0.58 | 0 | NA | |
129 | hsa-miR-362-3p | DTX1 | 0.11 | 0.64379 | -0.44 | 0.05658 | miRNATAP | -0.14 | 0.03937 | NA | |
130 | hsa-miR-362-3p | DZIP1 | 0.11 | 0.64379 | -0.41 | 0.08969 | miRanda | -0.39 | 0 | NA | |
131 | hsa-miR-362-3p | EDNRA | 0.11 | 0.64379 | 0.08 | 0.76309 | miRanda | -0.35 | 0 | NA | |
132 | hsa-miR-362-3p | EFNA5 | 0.11 | 0.64379 | -1.18 | 0.00241 | miRanda | -0.43 | 0.00017 | NA | |
133 | hsa-miR-362-3p | EGFLAM | 0.11 | 0.64379 | -0.37 | 0.0797 | MirTarget; miRanda; miRNATAP | -0.21 | 0.0008 | NA | |
134 | hsa-miR-362-3p | EGR3 | 0.11 | 0.64379 | -0.66 | 0.03342 | miRanda | -0.26 | 0.00372 | NA | |
135 | hsa-miR-362-3p | ELAVL2 | 0.11 | 0.64379 | 0.58 | 0.25933 | miRanda | -0.45 | 0.00289 | NA | |
136 | hsa-miR-362-3p | ELOVL4 | 0.11 | 0.64379 | -0.4 | 0.09604 | miRanda | -0.41 | 0 | NA | |
137 | hsa-miR-362-3p | ENPP6 | 0.11 | 0.64379 | -0.6 | 0.04536 | MirTarget; miRanda | -0.18 | 0.03197 | NA | |
138 | hsa-miR-362-3p | EPB41L3 | 0.11 | 0.64379 | -0.66 | 0.04938 | PITA; miRanda | -0.45 | 0 | NA | |
139 | hsa-miR-362-3p | EPHA3 | 0.11 | 0.64379 | -0.12 | 0.69472 | miRanda | -0.45 | 0 | NA | |
140 | hsa-miR-362-3p | EPHA4 | 0.11 | 0.64379 | -1.32 | 0.00041 | PITA; miRanda; miRNATAP | -0.4 | 0.00024 | NA | |
141 | hsa-miR-362-3p | EPHA7 | 0.11 | 0.64379 | -0.47 | 0.28753 | miRanda | -0.55 | 2.0E-5 | NA | |
142 | hsa-miR-362-3p | ETS1 | 0.11 | 0.64379 | -0.48 | 0.02266 | miRanda | -0.27 | 0 | NA | |
143 | hsa-miR-362-3p | EVI2A | 0.11 | 0.64379 | -0.53 | 0.0452 | miRanda | -0.33 | 1.0E-5 | NA | |
144 | hsa-miR-362-3p | EXOC3L2 | 0.11 | 0.64379 | -0.28 | 0.0604 | miRanda | -0.13 | 0.00303 | NA | |
145 | hsa-miR-362-3p | FAM126A | 0.11 | 0.64379 | -0.14 | 0.52106 | miRanda | -0.21 | 0.0012 | NA | |
146 | hsa-miR-362-3p | FAM129A | 0.11 | 0.64379 | -0.52 | 0.05188 | miRanda | -0.46 | 0 | NA | |
147 | hsa-miR-362-3p | FAM184A | 0.11 | 0.64379 | -0.26 | 0.4994 | miRanda | -0.34 | 0.00274 | NA | |
148 | hsa-miR-362-3p | FAM198A | 0.11 | 0.64379 | -0.5 | 0.1875 | miRanda | -0.46 | 3.0E-5 | NA | |
149 | hsa-miR-362-3p | FAM43B | 0.11 | 0.64379 | -0.6 | 0.11717 | miRanda | -0.55 | 0 | NA | |
150 | hsa-miR-362-3p | FAT3 | 0.11 | 0.64379 | -0.12 | 0.71946 | MirTarget; miRanda | -0.47 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 103 | 1672 | 9.584e-20 | 4.46e-16 |
2 | REGULATION OF CELL DIFFERENTIATION | 93 | 1492 | 4.107e-18 | 9.556e-15 |
3 | NEUROGENESIS | 88 | 1402 | 2.572e-17 | 3.989e-14 |
4 | CELL DEVELOPMENT | 87 | 1426 | 2.269e-16 | 2.64e-13 |
5 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 58 | 788 | 1.79e-14 | 1.235e-11 |
6 | REGULATION OF CELL DEVELOPMENT | 60 | 836 | 1.859e-14 | 1.235e-11 |
7 | CIRCULATORY SYSTEM DEVELOPMENT | 58 | 788 | 1.79e-14 | 1.235e-11 |
8 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 55 | 750 | 1.057e-13 | 6.146e-11 |
9 | REGULATION OF NEURON DIFFERENTIATION | 46 | 554 | 1.637e-13 | 8.461e-11 |
10 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 57 | 823 | 3.958e-13 | 1.842e-10 |
11 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 69 | 1142 | 7.353e-13 | 3.11e-10 |
12 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 78 | 1395 | 1.017e-12 | 3.945e-10 |
13 | VASCULATURE DEVELOPMENT | 40 | 469 | 2.938e-12 | 1.052e-09 |
14 | CELLULAR COMPONENT MORPHOGENESIS | 57 | 900 | 1.47e-11 | 4.886e-09 |
15 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 59 | 957 | 1.851e-11 | 5.677e-09 |
16 | ANGIOGENESIS | 30 | 293 | 1.952e-11 | 5.677e-09 |
17 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 61 | 1021 | 2.959e-11 | 8.098e-09 |
18 | BLOOD VESSEL MORPHOGENESIS | 33 | 364 | 5.084e-11 | 1.314e-08 |
19 | TISSUE DEVELOPMENT | 78 | 1518 | 6.568e-11 | 1.608e-08 |
20 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 34 | 408 | 2.489e-10 | 5.792e-08 |
21 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 87 | 1848 | 3.832e-10 | 8.042e-08 |
22 | NEURON DIFFERENTIATION | 53 | 874 | 3.928e-10 | 8.042e-08 |
23 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 49 | 771 | 3.975e-10 | 8.042e-08 |
24 | TAXIS | 36 | 464 | 5.244e-10 | 1.017e-07 |
25 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 38 | 513 | 6.374e-10 | 1.186e-07 |
26 | LOCOMOTION | 61 | 1114 | 9.516e-10 | 1.703e-07 |
27 | CELL PROJECTION ORGANIZATION | 53 | 902 | 1.198e-09 | 2.065e-07 |
28 | REGULATION OF CELL MORPHOGENESIS | 39 | 552 | 1.457e-09 | 2.421e-07 |
29 | RESPONSE TO ENDOGENOUS STIMULUS | 72 | 1450 | 1.781e-09 | 2.857e-07 |
30 | POSITIVE REGULATION OF CELL PROLIFERATION | 49 | 814 | 2.426e-09 | 3.762e-07 |
31 | REGULATION OF CELL PROLIFERATION | 73 | 1496 | 2.855e-09 | 4.286e-07 |
32 | RESPONSE TO EXTERNAL STIMULUS | 83 | 1821 | 4.834e-09 | 7.03e-07 |
33 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 33 | 437 | 5.526e-09 | 7.563e-07 |
34 | RESPONSE TO LIPID | 51 | 888 | 5.428e-09 | 7.563e-07 |
35 | NEURON DEVELOPMENT | 43 | 687 | 7.916e-09 | 1.052e-06 |
36 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 81 | 1784 | 9.164e-09 | 1.184e-06 |
37 | POSITIVE REGULATION OF CELL DEVELOPMENT | 34 | 472 | 1.057e-08 | 1.329e-06 |
38 | REGULATION OF CELL ADHESION | 40 | 629 | 1.75e-08 | 2.105e-06 |
39 | BIOLOGICAL ADHESION | 55 | 1032 | 1.765e-08 | 2.105e-06 |
40 | REGULATION OF CELL PROJECTION ORGANIZATION | 37 | 558 | 2.094e-08 | 2.435e-06 |
41 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 53 | 983 | 2.243e-08 | 2.545e-06 |
42 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 63 | 1275 | 2.553e-08 | 2.828e-06 |
43 | REGULATION OF HOMEOSTATIC PROCESS | 32 | 447 | 3.349e-08 | 3.624e-06 |
44 | NEURON PROJECTION MORPHOGENESIS | 30 | 402 | 3.62e-08 | 3.828e-06 |
45 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 27 | 337 | 4.142e-08 | 4.1e-06 |
46 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 50 | 917 | 4.082e-08 | 4.1e-06 |
47 | REGULATION OF CELL DEATH | 69 | 1472 | 4.083e-08 | 4.1e-06 |
48 | CELL PART MORPHOGENESIS | 39 | 633 | 6.175e-08 | 5.986e-06 |
49 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 14 | 98 | 7.922e-08 | 7.523e-06 |
50 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 306 | 9.071e-08 | 8.358e-06 |
51 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 24 | 285 | 9.341e-08 | 8.358e-06 |
52 | BEHAVIOR | 34 | 516 | 9.271e-08 | 8.358e-06 |
53 | NEURON PROJECTION DEVELOPMENT | 35 | 545 | 1.116e-07 | 9.793e-06 |
54 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 64 | 1360 | 1.177e-07 | 1.014e-05 |
55 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 53 | 1036 | 1.233e-07 | 1.024e-05 |
56 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 53 | 1036 | 1.233e-07 | 1.024e-05 |
57 | POSITIVE REGULATION OF CELL DEATH | 37 | 605 | 1.641e-07 | 1.339e-05 |
58 | REGULATION OF MAPK CASCADE | 39 | 660 | 1.832e-07 | 1.47e-05 |
59 | MULTI MULTICELLULAR ORGANISM PROCESS | 20 | 213 | 1.936e-07 | 1.501e-05 |
60 | REGULATION OF SYSTEM PROCESS | 33 | 507 | 1.91e-07 | 1.501e-05 |
61 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 64 | 1381 | 2.039e-07 | 1.555e-05 |
62 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 27 | 368 | 2.476e-07 | 1.858e-05 |
63 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 51 | 1008 | 3.047e-07 | 2.246e-05 |
64 | EXTRACELLULAR STRUCTURE ORGANIZATION | 24 | 304 | 3.09e-07 | 2.246e-05 |
65 | POSITIVE REGULATION OF LOCOMOTION | 29 | 420 | 3.184e-07 | 2.28e-05 |
66 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 46 | 872 | 3.793e-07 | 2.674e-05 |
67 | SKELETAL SYSTEM DEVELOPMENT | 30 | 455 | 5.302e-07 | 3.682e-05 |
68 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 11 | 68 | 5.466e-07 | 3.74e-05 |
69 | REGULATION OF AXONOGENESIS | 17 | 168 | 5.586e-07 | 3.767e-05 |
70 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 76 | 1805 | 6e-07 | 3.988e-05 |
71 | CELL MOTILITY | 44 | 835 | 7.103e-07 | 4.528e-05 |
72 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 10 | 56 | 6.952e-07 | 4.528e-05 |
73 | LOCALIZATION OF CELL | 44 | 835 | 7.103e-07 | 4.528e-05 |
74 | UROGENITAL SYSTEM DEVELOPMENT | 23 | 299 | 8.575e-07 | 5.392e-05 |
75 | INTRACELLULAR SIGNAL TRANSDUCTION | 68 | 1572 | 1.006e-06 | 6.24e-05 |
76 | POSITIVE REGULATION OF MAPK CASCADE | 30 | 470 | 1.042e-06 | 6.38e-05 |
77 | PROTEIN PHOSPHORYLATION | 47 | 944 | 1.432e-06 | 8.655e-05 |
78 | REGULATION OF CHEMOTAXIS | 17 | 180 | 1.473e-06 | 8.784e-05 |
79 | LOCOMOTORY BEHAVIOR | 17 | 181 | 1.59e-06 | 9.366e-05 |
80 | ORGAN MORPHOGENESIS | 43 | 841 | 2.093e-06 | 0.0001217 |
81 | HEART DEVELOPMENT | 29 | 466 | 2.611e-06 | 0.00015 |
82 | CELL CELL SIGNALING | 40 | 767 | 2.995e-06 | 0.0001699 |
83 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 19 | 232 | 3.085e-06 | 0.0001709 |
84 | NEGATIVE CHEMOTAXIS | 8 | 39 | 3.074e-06 | 0.0001709 |
85 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 17 | 191 | 3.328e-06 | 0.0001822 |
86 | EPITHELIUM DEVELOPMENT | 46 | 945 | 3.407e-06 | 0.0001822 |
87 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 48 | 1004 | 3.374e-06 | 0.0001822 |
88 | REGULATION OF CELL SIZE | 16 | 172 | 3.644e-06 | 0.0001927 |
89 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 22 | 303 | 3.82e-06 | 0.0001975 |
90 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 22 | 303 | 3.82e-06 | 0.0001975 |
91 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 52 | 1135 | 4.392e-06 | 0.0002246 |
92 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 17 | 197 | 5.057e-06 | 0.0002451 |
93 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 20 | 262 | 4.978e-06 | 0.0002451 |
94 | REGULATION OF CELL CELL ADHESION | 25 | 380 | 4.917e-06 | 0.0002451 |
95 | REGULATION OF EXTENT OF CELL GROWTH | 12 | 101 | 4.931e-06 | 0.0002451 |
96 | NEGATIVE REGULATION OF CELL PROLIFERATION | 35 | 643 | 5.037e-06 | 0.0002451 |
97 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 67 | 1618 | 5.405e-06 | 0.0002593 |
98 | REGULATION OF ION TRANSPORT | 33 | 592 | 5.749e-06 | 0.000273 |
99 | RESPONSE TO ALCOHOL | 24 | 362 | 6.674e-06 | 0.0003137 |
100 | HEAD DEVELOPMENT | 37 | 709 | 7.013e-06 | 0.0003263 |
101 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 28 | 465 | 7.23e-06 | 0.0003331 |
102 | POSITIVE REGULATION OF GENE EXPRESSION | 70 | 1733 | 7.571e-06 | 0.0003454 |
103 | DIVALENT INORGANIC CATION HOMEOSTASIS | 23 | 343 | 8.623e-06 | 0.0003785 |
104 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 40 | 801 | 8.419e-06 | 0.0003785 |
105 | NEURON PROJECTION GUIDANCE | 17 | 205 | 8.604e-06 | 0.0003785 |
106 | REGULATION OF BLOOD CIRCULATION | 21 | 295 | 8.576e-06 | 0.0003785 |
107 | REGULATION OF SEQUESTERING OF CALCIUM ION | 12 | 107 | 9.018e-06 | 0.0003922 |
108 | REGULATION OF CELL MATRIX ADHESION | 11 | 90 | 9.279e-06 | 0.0003998 |
109 | REGULATION OF HYDROLASE ACTIVITY | 57 | 1327 | 1.026e-05 | 0.0004373 |
110 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 33 | 609 | 1.034e-05 | 0.0004373 |
111 | SENSORY PERCEPTION OF PAIN | 10 | 75 | 1.082e-05 | 0.0004536 |
112 | REGULATION OF CALCIUM ION TRANSPORT | 17 | 209 | 1.11e-05 | 0.000459 |
113 | SYNAPTIC SIGNALING | 26 | 424 | 1.117e-05 | 0.000459 |
114 | MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 9 | 60 | 1.125e-05 | 0.000459 |
115 | REGULATION OF METAL ION TRANSPORT | 22 | 325 | 1.165e-05 | 0.0004713 |
116 | TISSUE MORPHOGENESIS | 30 | 533 | 1.276e-05 | 0.0005116 |
117 | STEM CELL DIFFERENTIATION | 16 | 190 | 1.301e-05 | 0.0005173 |
118 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 75 | 1929 | 1.312e-05 | 0.0005175 |
119 | POSITIVE REGULATION OF CELL COMMUNICATION | 63 | 1532 | 1.325e-05 | 0.0005181 |
120 | REGULATION OF GTPASE ACTIVITY | 35 | 673 | 1.342e-05 | 0.0005204 |
121 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 25 | 404 | 1.411e-05 | 0.0005425 |
122 | CELLULAR RESPONSE TO LIPID | 27 | 457 | 1.479e-05 | 0.0005641 |
123 | POSITIVE REGULATION OF HOMEOSTATIC PROCESS | 17 | 216 | 1.707e-05 | 0.0006459 |
124 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 37 | 740 | 1.801e-05 | 0.000676 |
125 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 154 | 1.907e-05 | 0.00071 |
126 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 13 | 135 | 2.043e-05 | 0.0007546 |
127 | REGULATION OF DEVELOPMENTAL GROWTH | 20 | 289 | 2.109e-05 | 0.0007726 |
128 | EMBRYO DEVELOPMENT | 42 | 894 | 2.15e-05 | 0.0007817 |
129 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 66 | 1656 | 2.179e-05 | 0.0007837 |
130 | BONE DEVELOPMENT | 14 | 156 | 2.206e-05 | 0.0007837 |
131 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 61 | 1492 | 2.193e-05 | 0.0007837 |
132 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 43 | 926 | 2.256e-05 | 0.0007953 |
133 | REGULATION OF HEART CONTRACTION | 17 | 221 | 2.295e-05 | 0.0008028 |
134 | CIRCULATORY SYSTEM PROCESS | 23 | 366 | 2.435e-05 | 0.0008406 |
135 | RESPONSE TO STEROID HORMONE | 28 | 497 | 2.439e-05 | 0.0008406 |
136 | TUBE DEVELOPMENT | 30 | 552 | 2.475e-05 | 0.0008468 |
137 | CELL CELL ADHESION | 32 | 608 | 2.502e-05 | 0.0008497 |
138 | REGULATION OF JNK CASCADE | 14 | 159 | 2.732e-05 | 0.0009212 |
139 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 67 | 2.808e-05 | 0.0009401 |
140 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 20 | 296 | 2.97e-05 | 0.0009627 |
141 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 41 | 876 | 2.944e-05 | 0.0009627 |
142 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 16 | 203 | 2.954e-05 | 0.0009627 |
143 | REGULATION OF DENDRITE DEVELOPMENT | 12 | 120 | 2.905e-05 | 0.0009627 |
144 | POSITIVE REGULATION OF OSSIFICATION | 10 | 84 | 2.979e-05 | 0.0009627 |
145 | REGULATION OF PROTEIN MODIFICATION PROCESS | 67 | 1710 | 3.197e-05 | 0.001026 |
146 | CELL CHEMOTAXIS | 14 | 162 | 3.365e-05 | 0.001047 |
147 | RESPONSE TO INORGANIC SUBSTANCE | 27 | 479 | 3.371e-05 | 0.001047 |
148 | CYTOSOLIC CALCIUM ION TRANSPORT | 8 | 53 | 3.31e-05 | 0.001047 |
149 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 11 | 103 | 3.374e-05 | 0.001047 |
150 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 19 | 274 | 3.285e-05 | 0.001047 |
151 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 15 | 184 | 3.528e-05 | 0.001087 |
152 | POSITIVE REGULATION OF CELL ADHESION | 23 | 376 | 3.707e-05 | 0.001135 |
153 | POSITIVE REGULATION OF KINASE ACTIVITY | 27 | 482 | 3.754e-05 | 0.001142 |
154 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 69 | 1791 | 4.092e-05 | 0.001236 |
155 | POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 6 | 28 | 4.201e-05 | 0.001261 |
156 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 17 | 232 | 4.256e-05 | 0.00127 |
157 | RESPONSE TO HORMONE | 41 | 893 | 4.54e-05 | 0.001346 |
158 | ENDOTHELIAL CELL DIFFERENTIATION | 9 | 72 | 5.034e-05 | 0.001483 |
159 | SINGLE ORGANISM BEHAVIOR | 23 | 384 | 5.126e-05 | 0.001491 |
160 | REGULATION OF TRANSPORT | 69 | 1804 | 5.125e-05 | 0.001491 |
161 | CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 7 | 42 | 5.357e-05 | 0.001539 |
162 | CALCIUM ION IMPORT INTO CYTOSOL | 7 | 42 | 5.357e-05 | 0.001539 |
163 | REGULATION OF GROWTH | 32 | 633 | 5.424e-05 | 0.001543 |
164 | ENDOTHELIUM DEVELOPMENT | 10 | 90 | 5.439e-05 | 0.001543 |
165 | SENSORY ORGAN DEVELOPMENT | 27 | 493 | 5.517e-05 | 0.001556 |
166 | LEUKOCYTE ACTIVATION | 24 | 414 | 5.921e-05 | 0.00165 |
167 | EPITHELIAL CELL DIFFERENTIATION | 27 | 495 | 5.908e-05 | 0.00165 |
168 | REGULATION OF ACUTE INFLAMMATORY RESPONSE | 9 | 74 | 6.269e-05 | 0.001736 |
169 | CONNECTIVE TISSUE DEVELOPMENT | 15 | 194 | 6.487e-05 | 0.001786 |
170 | CELL DEATH | 44 | 1001 | 6.602e-05 | 0.001807 |
171 | REGULATION OF CELL GROWTH | 23 | 391 | 6.747e-05 | 0.001836 |
172 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 13 | 153 | 7.599e-05 | 0.002056 |
173 | MATERNAL PLACENTA DEVELOPMENT | 6 | 31 | 7.729e-05 | 0.002079 |
174 | REGULATION OF SYNAPSE ORGANIZATION | 11 | 113 | 7.952e-05 | 0.002114 |
175 | REGULATION OF STEM CELL DIFFERENTIATION | 11 | 113 | 7.952e-05 | 0.002114 |
176 | RESPONSE TO ACID CHEMICAL | 20 | 319 | 8.434e-05 | 0.00223 |
177 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 11 | 114 | 8.617e-05 | 0.002265 |
178 | REGULATION OF FEVER GENERATION | 4 | 11 | 9.08e-05 | 0.002374 |
179 | RESPONSE TO CALCIUM ION | 11 | 115 | 9.328e-05 | 0.002425 |
180 | REGULATION OF OSSIFICATION | 14 | 178 | 9.406e-05 | 0.002431 |
181 | REGULATION OF ION HOMEOSTASIS | 15 | 201 | 9.683e-05 | 0.002489 |
182 | TUBE MORPHOGENESIS | 20 | 323 | 9.996e-05 | 0.002555 |
183 | CELL ACTIVATION | 29 | 568 | 0.000102 | 0.002592 |
184 | REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 9 | 79 | 0.0001051 | 0.002659 |
185 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 13 | 159 | 0.0001124 | 0.002828 |
186 | REGULATION OF CARTILAGE DEVELOPMENT | 8 | 63 | 0.0001176 | 0.002925 |
187 | REGULATION OF CELL KILLING | 8 | 63 | 0.0001176 | 0.002925 |
188 | REGULATION OF JUN KINASE ACTIVITY | 9 | 81 | 0.0001278 | 0.003164 |
189 | NEGATIVE REGULATION OF CELL COMMUNICATION | 49 | 1192 | 0.0001314 | 0.003234 |
190 | RESPONSE TO FLUID SHEAR STRESS | 6 | 34 | 0.0001329 | 0.003255 |
191 | POSITIVE REGULATION OF CHEMOTAXIS | 11 | 120 | 0.0001369 | 0.003334 |
192 | RESPONSE TO METAL ION | 20 | 333 | 0.0001507 | 0.003652 |
193 | REGULATION OF RESPONSE TO WOUNDING | 23 | 413 | 0.0001523 | 0.003672 |
194 | IMMUNE SYSTEM DEVELOPMENT | 29 | 582 | 0.0001547 | 0.00371 |
195 | REGULATION OF CARDIAC CONDUCTION | 8 | 66 | 0.0001639 | 0.00391 |
196 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 7 | 50 | 0.0001684 | 0.003998 |
197 | REGULATION OF ADAPTIVE IMMUNE RESPONSE | 11 | 123 | 0.0001705 | 0.004026 |
198 | REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 166 | 0.0001732 | 0.004026 |
199 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 25 | 472 | 0.0001739 | 0.004026 |
200 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 13 | 166 | 0.0001732 | 0.004026 |
201 | REGULATION OF IMMUNE SYSTEM PROCESS | 55 | 1403 | 0.0001718 | 0.004026 |
202 | REGULATION OF CELLULAR COMPONENT SIZE | 20 | 337 | 0.0001766 | 0.004049 |
203 | RESPONSE TO OXYGEN LEVELS | 19 | 311 | 0.0001762 | 0.004049 |
204 | CARDIOBLAST DIFFERENTIATION | 4 | 13 | 0.0001894 | 0.004321 |
205 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 36 | 799 | 0.0001917 | 0.004351 |
206 | NEGATIVE REGULATION OF LOCOMOTION | 17 | 263 | 0.0001971 | 0.004453 |
207 | REGULATION OF HEMOPOIESIS | 19 | 314 | 0.0001992 | 0.004477 |
208 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 10 | 106 | 0.0002162 | 0.004836 |
209 | PEPTIDYL SERINE MODIFICATION | 12 | 148 | 0.0002212 | 0.004911 |
210 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 58 | 1518 | 0.0002217 | 0.004911 |
211 | EMBRYONIC MORPHOGENESIS | 27 | 539 | 0.0002385 | 0.005234 |
212 | REGULATION OF TRANSMEMBRANE TRANSPORT | 23 | 426 | 0.0002385 | 0.005234 |
213 | REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 7 | 53 | 0.0002444 | 0.00534 |
214 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 8 | 70 | 0.000248 | 0.005391 |
215 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 6 | 38 | 0.0002518 | 0.005449 |
216 | REGULATION OF CELL ACTIVATION | 25 | 484 | 0.0002547 | 0.005487 |
217 | CHEMICAL HOMEOSTASIS | 38 | 874 | 0.0002597 | 0.005531 |
218 | RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE | 4 | 14 | 0.0002602 | 0.005531 |
219 | REGULATION OF CELL SUBSTRATE ADHESION | 13 | 173 | 0.0002603 | 0.005531 |
220 | PHOSPHORYLATION | 49 | 1228 | 0.0002638 | 0.005579 |
221 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 33 | 724 | 0.0002876 | 0.006055 |
222 | REGULATION OF AXON GUIDANCE | 6 | 39 | 0.0002917 | 0.006086 |
223 | MUSCLE STRUCTURE DEVELOPMENT | 23 | 432 | 0.0002911 | 0.006086 |
224 | POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 11 | 131 | 0.0002964 | 0.006157 |
225 | CALCIUM ION TRANSPORT | 15 | 223 | 0.0003023 | 0.006251 |
226 | AMEBOIDAL TYPE CELL MIGRATION | 12 | 154 | 0.0003195 | 0.006552 |
227 | EYE DEVELOPMENT | 19 | 326 | 0.0003196 | 0.006552 |
228 | SKELETAL SYSTEM MORPHOGENESIS | 14 | 201 | 0.0003346 | 0.006829 |
229 | REGULATION OF HEAT GENERATION | 4 | 15 | 0.0003482 | 0.007076 |
230 | OSSIFICATION | 16 | 251 | 0.0003518 | 0.007117 |
231 | MESENCHYMAL CELL DIFFERENTIATION | 11 | 134 | 0.0003604 | 0.00726 |
232 | OVULATION CYCLE | 10 | 113 | 0.0003637 | 0.007295 |
233 | CELL FATE COMMITMENT | 15 | 227 | 0.0003653 | 0.007295 |
234 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 10 | 114 | 0.0003904 | 0.00773 |
235 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 14 | 204 | 0.0003888 | 0.00773 |
236 | REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 8 | 75 | 0.0003997 | 0.00788 |
237 | RESPONSE TO ABIOTIC STIMULUS | 42 | 1024 | 0.0004202 | 0.00825 |
238 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 18 | 307 | 0.0004245 | 0.008299 |
239 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 37 | 867 | 0.0004449 | 0.008662 |
240 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 10 | 116 | 0.0004487 | 0.008699 |
241 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 4 | 16 | 0.0004557 | 0.008797 |
242 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 15 | 232 | 0.0004597 | 0.008838 |
243 | RESPONSE TO GROWTH FACTOR | 24 | 475 | 0.0004621 | 0.008848 |
244 | LEUKOCYTE CHEMOTAXIS | 10 | 117 | 0.0004804 | 0.009125 |
245 | POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 7 | 59 | 0.0004788 | 0.009125 |
246 | IMMUNE SYSTEM PROCESS | 70 | 1984 | 0.0004919 | 0.009304 |
247 | CELL JUNCTION ORGANIZATION | 13 | 185 | 0.0004969 | 0.00936 |
248 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 12 | 162 | 0.0005061 | 0.009495 |
249 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 38 | 905 | 0.0005085 | 0.009502 |
250 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 18 | 312 | 0.0005138 | 0.009562 |
251 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 11 | 140 | 0.0005237 | 0.009708 |
252 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 7 | 60 | 0.0005311 | 0.009806 |
253 | HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 98 | 0.0005409 | 0.009948 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 37 | 629 | 4.272e-07 | 0.0003969 |
2 | SIGNAL TRANSDUCER ACTIVITY | 71 | 1731 | 3.794e-06 | 0.001266 |
3 | RECEPTOR BINDING | 63 | 1476 | 4.09e-06 | 0.001266 |
4 | PROTEIN KINASE ACTIVITY | 33 | 640 | 2.814e-05 | 0.003839 |
5 | GLYCOSAMINOGLYCAN BINDING | 16 | 205 | 3.329e-05 | 0.003839 |
6 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 17 | 228 | 3.417e-05 | 0.003839 |
7 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 51 | 1199 | 4.01e-05 | 0.003839 |
8 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 20 | 303 | 4.132e-05 | 0.003839 |
9 | CHEMOREPELLENT ACTIVITY | 6 | 27 | 3.368e-05 | 0.003839 |
10 | GROWTH FACTOR BINDING | 12 | 123 | 3.717e-05 | 0.003839 |
11 | REGULATORY REGION NUCLEIC ACID BINDING | 38 | 818 | 6.782e-05 | 0.004707 |
12 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 20 | 315 | 7.093e-05 | 0.004707 |
13 | RECEPTOR ACTIVITY | 64 | 1649 | 6.485e-05 | 0.004707 |
14 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 14 | 172 | 6.498e-05 | 0.004707 |
15 | EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 9 | 76 | 7.75e-05 | 0.0048 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SYNAPSE | 47 | 754 | 1.738e-09 | 1.015e-06 |
2 | NEURON PART | 63 | 1265 | 1.906e-08 | 5.565e-06 |
3 | NEURON PROJECTION | 50 | 942 | 9.424e-08 | 1.835e-05 |
4 | SYNAPSE PART | 37 | 610 | 2.013e-07 | 2.939e-05 |
5 | MEMBRANE REGION | 54 | 1134 | 8.874e-07 | 0.0001037 |
6 | EXTRACELLULAR MATRIX | 27 | 426 | 4.134e-06 | 0.0002864 |
7 | EXCITATORY SYNAPSE | 17 | 197 | 5.057e-06 | 0.0002864 |
8 | SECRETORY VESICLE | 28 | 461 | 6.152e-06 | 0.0002864 |
9 | POSTSYNAPSE | 25 | 378 | 4.482e-06 | 0.0002864 |
10 | CELL SURFACE | 39 | 757 | 5.326e-06 | 0.0002864 |
11 | MEMBRANE MICRODOMAIN | 21 | 288 | 5.927e-06 | 0.0002864 |
12 | CELL PROJECTION | 73 | 1786 | 3.072e-06 | 0.0002864 |
13 | SOMATODENDRITIC COMPARTMENT | 35 | 650 | 6.375e-06 | 0.0002864 |
14 | EXTRACELLULAR SPACE | 59 | 1376 | 7.454e-06 | 0.000311 |
15 | DENDRITE | 27 | 451 | 1.168e-05 | 0.0004549 |
16 | CELL JUNCTION | 51 | 1151 | 1.365e-05 | 0.0004982 |
17 | PROTEINACEOUS EXTRACELLULAR MATRIX | 23 | 356 | 1.57e-05 | 0.0005394 |
18 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 66 | 1649 | 1.908e-05 | 0.0006191 |
19 | CELL BODY | 27 | 494 | 5.71e-05 | 0.001755 |
20 | SECRETORY GRANULE | 21 | 352 | 0.0001139 | 0.003326 |
21 | EXOCYTIC VESICLE | 12 | 142 | 0.00015 | 0.00417 |
22 | PRESYNAPSE | 18 | 283 | 0.0001579 | 0.00419 |
23 | EXTERNAL SIDE OF PLASMA MEMBRANE | 16 | 238 | 0.0001935 | 0.004709 |
24 | DENSE CORE GRANULE | 4 | 13 | 0.0001894 | 0.004709 |
25 | RECEPTOR COMPLEX | 19 | 327 | 0.0003321 | 0.007757 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Cytokine_cytokine_receptor_interaction_hsa04060 | 18 | 270 | 8.736e-05 | 0.002437 | |
2 | Rap1_signaling_pathway_hsa04015 | 15 | 206 | 0.0001274 | 0.002437 | |
3 | ECM_receptor_interaction_hsa04512 | 9 | 82 | 0.0001406 | 0.002437 | |
4 | Hippo_signaling_pathway_hsa04390 | 12 | 154 | 0.0003195 | 0.003565 | |
5 | Apelin_signaling_pathway_hsa04371 | 11 | 137 | 0.0004357 | 0.003565 | |
6 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 11 | 139 | 0.0004928 | 0.003565 | |
7 | cGMP_PKG_signaling_pathway_hsa04022 | 12 | 163 | 0.0005348 | 0.003565 | |
8 | Hippo_signaling_pathway_multiple_species_hsa04392 | 5 | 29 | 0.0005484 | 0.003565 | |
9 | cAMP_signaling_pathway_hsa04024 | 13 | 198 | 0.0009374 | 0.005416 | |
10 | Calcium_signaling_pathway_hsa04020 | 12 | 182 | 0.001403 | 0.007297 | |
11 | MAPK_signaling_pathway_hsa04010 | 16 | 295 | 0.001949 | 0.009215 | |
12 | Phospholipase_D_signaling_pathway_hsa04072 | 10 | 146 | 0.002599 | 0.01126 | |
13 | Gap_junction_hsa04540 | 7 | 88 | 0.004954 | 0.01982 | |
14 | Neuroactive_ligand_receptor_interaction_hsa04080 | 14 | 278 | 0.006921 | 0.02571 | |
15 | Cell_adhesion_molecules_.CAMs._hsa04514 | 9 | 145 | 0.007883 | 0.02667 | |
16 | Focal_adhesion_hsa04510 | 11 | 199 | 0.008205 | 0.02667 | |
17 | Ras_signaling_pathway_hsa04014 | 12 | 232 | 0.009775 | 0.0299 | |
18 | Regulation_of_actin_cytoskeleton_hsa04810 | 11 | 208 | 0.0112 | 0.03236 | |
19 | PI3K_Akt_signaling_pathway_hsa04151 | 15 | 352 | 0.02171 | 0.05652 | |
20 | ABC_transporters_hsa02010 | 4 | 45 | 0.02174 | 0.05652 | |
21 | NF_kappa_B_signaling_pathway_hsa04064 | 6 | 95 | 0.02569 | 0.06362 | |
22 | TGF_beta_signaling_pathway_hsa04350 | 5 | 84 | 0.04967 | 0.1174 | |
23 | Oocyte_meiosis_hsa04114 | 6 | 124 | 0.07545 | 0.1706 | |
24 | Cellular_senescence_hsa04218 | 7 | 160 | 0.08759 | 0.1898 | |
25 | Jak_STAT_signaling_pathway_hsa04630 | 7 | 162 | 0.09206 | 0.1915 | |
26 | Wnt_signaling_pathway_hsa04310 | 6 | 146 | 0.135 | 0.2699 | |
27 | ErbB_signaling_pathway_hsa04012 | 4 | 85 | 0.1437 | 0.2768 | |
28 | AMPK_signaling_pathway_hsa04152 | 5 | 121 | 0.1612 | 0.2955 | |
29 | VEGF_signaling_pathway_hsa04370 | 3 | 59 | 0.1648 | 0.2955 | |
30 | Autophagy_animal_hsa04140 | 5 | 128 | 0.189 | 0.3276 | |
31 | Notch_signaling_pathway_hsa04330 | 2 | 48 | 0.3162 | 0.5305 | |
32 | FoxO_signaling_pathway_hsa04068 | 4 | 132 | 0.3834 | 0.6231 | |
33 | Apoptosis_hsa04210 | 4 | 138 | 0.4156 | 0.6549 | |
34 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.4591 | 0.7022 | |
35 | TNF_signaling_pathway_hsa04668 | 3 | 108 | 0.4748 | 0.7055 | |
36 | Endocytosis_hsa04144 | 6 | 244 | 0.5232 | 0.7545 | |
37 | Tight_junction_hsa04530 | 4 | 170 | 0.5771 | 0.7897 | |
38 | Phosphatidylinositol_signaling_system_hsa04070 | 2 | 99 | 0.6852 | 0.8658 | |
39 | HIF_1_signaling_pathway_hsa04066 | 2 | 100 | 0.6905 | 0.8658 | |
40 | mTOR_signaling_pathway_hsa04150 | 3 | 151 | 0.6993 | 0.8658 | |
41 | Sphingolipid_signaling_pathway_hsa04071 | 2 | 118 | 0.7739 | 0.9308 | |
42 | Lysosome_hsa04142 | 2 | 123 | 0.7933 | 0.9308 | |
43 | Phagosome_hsa04145 | 2 | 152 | 0.8793 | 0.9526 | |
44 | Necroptosis_hsa04217 | 2 | 164 | 0.9041 | 0.9594 |